|产品英文名称||P44/42 MAPK (ERK1/2) Monoclonal Antibody|
|反应性||人, 大鼠, 小鼠|
|分子量||44, 42 KD|
|背景||MAPK1 (mitogen-activated protein kinase 1) encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs， act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for MAPK1.|
|别名||MAPK3; ERK1; PRKM3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p|
Fig.1. Western blot analysis of 1) Mouse Brain Tissue, 2) Rat Brain Tissue with P44/42 MAPK (ERK1/2) Mouse mAb diluted at 1:2000.
Fig.2. Immunohistochemical analysis of paraffin-embedded Human Breast Carcinoma using P44/42 MAPK (ERK1/2) Mouse mAb diluted at 1:200.